MedPath

Thiotepa

Thiotepa for Injection

Approved
Approval ID

0def6a5e-4bf5-b1fd-47b7-0f17ecfd9bc2

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 25, 2018

Manufacturers
FDA

Dr.Reddy's Laboratories Inc.,

DUNS: 802315887

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Thiotepa

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code43598-650
Application NumberANDA210337
Product Classification
M
Marketing Category
C73584
G
Generic Name
Thiotepa
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAVESICAL, INTRACAVITARY
Effective DateSeptember 21, 2017
FDA Product Classification

INGREDIENTS (2)

ThiotepaActive
Quantity: 15 mg in 1 1
Code: 905Z5W3GKH
Classification: ACTIB
WaterInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Thiotepa - FDA Drug Approval Details